Saudia Cargo has announced its agreement with IATA to work on its Center of Excellence for Independent Validators for Pharmaceutical Logistics (CEIV Pharma) Certification, the global standards in the safe and secure air transportation and handling of pharmaceuticals.
Saudia Cargo CEO Teddy Zebitz and IATA Senior Vice President Commercial Products and Services Mr. Frederic Leger signed the agreement at World Cargo Symposium, held in London.
For the next few months, Saudia Cargo will continue rigorous preparations across multiple aspects of its operations, particularly on staff competency to handle pharmaceuticals, to comply with IATA’s requirements for CEIV Pharma Certification on top of GDP (Good Distribution Practice).
The process is meant to ensure that critical healthcare cargo such as COVID-19 vaccines and other pharmaceutical and bioscience products are not compromised while they are being transported on air.
Commenting on this milestone to Saudia Cargo’s continuing drive as a globally competitive market leader, Teddy Zebitz, the company’s Chief Executive Officer, said: “This move shows Saudia Cargo’s commitment to the highest global quality standards and compliance when it comes to transporting pharmaceuticals and life sciences products. Human lives are paramount in our operations whether it involves staff or end-users. This give our customers and partners the continued confidence and peace of mind that the pharmaceuticals we transport are treated with utmost care in line with international standards.”